Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2132-2136

  Shinabarger, Dean L ^a   Marotti, Keith R ^a   Murray, Robert W ^a   Lin, Alice H ^a   Melchior, Earline P ^a   Swaney, Steve M ^a   Dunyak, Donna S ^a   Demyan, William F ^a   Buysse, Jerry M ^a,b  

^a PFIZER INC   (United States)

^b Microcide Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPEREZOLID; KASUGAMYCIN; LINEZOLID; OXAZOLIDINE DERIVATIVE; RNA; STREPTOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION;

EID: 0030793842     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2132     Document Type: Article

References (21)

1. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulanowicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Synthesis of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multi-drug resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679.
2. Daly, J. S., G. M. Eliopoulos, S. Wiley, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
3. Davies, J., L. Gorini, and B. D. Davis. 1965. Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol. Pharmacol. 1:93-106.
4. Eustice, D. C., P. A. Feldman, and A. M. Slee. 1988. Mechanism of action of Dup721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
5. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of Dup 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
6. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, Jr., D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766. novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
7. Ganoza, M. C., K. Buckingham, P. Hader, and T. Neilson. 1984. Effect of base sequence on in vitro protein chain termination. J. Biol. Chem. 259: 14101-14104.
8. Girbes, T., B. Cabrer, and J. Modolell. 1979. Preparation and assay of purified Escherichia coli polysomes devoid of free ribosomal subunits and endogenous GTPase activities. Methods Enzymol. 59:353-363.
9. Grise-Miron, L., J. Noreau, P. Melancon, and L. Brakier-Gingras. 1981. Comparison of the misreading induced by streptomycin and neomycin. Biochim. Biophys. Acta 656:103-110.
10. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
11. Kaatz, G. W., and S. M. Seo. 1996. In vitro activities of oxazolidinone compounds U-100592 and U-100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:799-801.
12. Mahmood, R., P. Compagnone-Post, and S. A. Khan. 1991. An in vitro transcription-translation system from Staphylococcus aureus. Gene 106:29-34.
13. Mason, E. O., L. B. Lamberth, and S. L. Kaplan. 1996. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:1039-1040.
14. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
15. National Committee for Clinical Laboratory Standards. 1993. Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Pratt, J. M. 1984. Coupled transcription-translation in prokaryotic cell-tree systems, p. 179-200. In B. D. Hames and S. J. Higgens (ed.), Transcription and translation. IRL Press, Oxford, England.
17. Rheinberger, H. J., U. Geigenmuller, M. Wedde, and K. Nierhaus. 1988. Parameters for the preparation of Escherichia coli ribosomes and ribosomal subunits active in tRNA binding. Methods Enzymol. 164:658-670.
18. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones: a new class of synthetic antibacterial agents: in vitro and in vivo activities of Dup105 and Dup721. Antimicrob. Agents Chemother. 31:1791-1797.
19. Tate W. P., C. M. Brown, and B. Kastner. 1990. Codon recognition by the polypeptide release factor, p. 393-101. In W. E. Hill, A. Dahlberg, R. A. Garrett, P. B. Moore, D. Schlessinger, and J. R. Warner (ed.), The ribosome: structure, function, and evolution. American Society for Microbiology, Washington, D.C.
20. Tate, W. P., and C. T. Caskey. 1990. Termination of protein synthesis, 81-100. In G. Spedding (ed.), Ribosomes and protein synthesis: a practical approach. Oxford University Press, New York, N.Y.
21. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766. novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.